Insta
Serum Institute Sees Big Expansion In Covishield Production In June; Has Already Produced Over 10 Crore Jabs
Serum Institute of India (Pic Via Twitter)
Expanding its production capacity in a big way, Pune-based vaccine maker Serum Institute of India (SII) has already produced over 10 crore doses of Covishield in the ongoing month of June so far, reports Economic Times.
As per the information provided by SII to the Drugs Controller General of India (DCGI), the company has sent 45 batches of Covishield, amounting to 10.8 crore doses to the Central Drugs Laboratory (CDL), Kasauli for release in June.
This gains significance as it comes at a time when India has been ramping up the daily vaccinations under the nationwide inoculation drive against COVID-19.
It should be noted that in May, SII's director for government and regulatory affairs, Prakash Kumar Singh had written to Union Minister for Home Affairs Amit Shah that the vaccine's production would be ramped up to 10 crore doses in June.
He had said, "We are committed to enhancing the production capacity of our Covishield vaccine and have been working round-the-clock in spite of various challenges being faced by us because of COVID-19 pandemic. We are pleased to inform that in the month of June we will be able to manufacture and supply nine to 10 crore doses of our Covishield vaccine to our country as compared to our present production capacity of 6.5 crore doses in May."
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.
Latest
